Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 07/28 03:59:58 pm
173.125 EUR   +0.54%
03:05aMARKETMIND : Gearing up for Jay
RE
07/27MERCK KGAA : JP Morgan remains its Buy rating
MD
07/27DGAP-PVR : Merck KGaA: Release according to -4-
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/22/2021 07/23/2021 07/26/2021 07/27/2021 07/28/2021 Date
170.05(c) 173.95(c) 171.85(c) 172.2(c) 173.3 Last
240 854 344 260 206 250 171 323 222 477 Volume
+1.43% +2.29% -1.21% +0.20% +0.64% Change
More quotes
Estimated financial data (e)
Sales 2021 18 932 M 22 403 M 22 403 M
Net income 2021 2 584 M 3 058 M 3 058 M
Net Debt 2021 8 918 M 10 554 M 10 554 M
P/E ratio 2021 28,7x
Yield 2021 0,88%
Sales 2022 19 923 M 23 576 M 23 576 M
Net income 2022 2 778 M 3 288 M 3 288 M
Net Debt 2022 6 853 M 8 110 M 8 110 M
P/E ratio 2022 27,0x
Yield 2022 0,92%
Capitalization 75 347 M 88 958 M 89 163 M
EV / Sales 2021 4,45x
EV / Sales 2022 4,13x
Nbr of Employees 57 850
Free-Float 29,7%
More Financials
Company
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The... 
Sector
Pharmaceuticals
Calendar
08/05 | 01:00amEarnings Release
More about the company
Ratings of Merck KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about MERCK KGAA
03:05aMARKETMIND : Gearing up for Jay
RE
07/27MERCK KGAA : JP Morgan remains its Buy rating
MD
07/27DGAP-PVR : Merck KGaA: Release according to -4-
DJ
07/27DGAP-PVR : Merck KGaA: Release according to -2-
DJ
07/27DGAP-PVR : Merck KGaA: Release according to -3-
DJ
07/27DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t..
DJ
07/27MARKETMIND : Great Q2 but what's next?
RE
07/27Artios raises USD153m in Series C financing
DJ
07/27PRESS RELEASE : Organon and ObsEva Enter Global License Agreement to Develop and..
DJ
07/26Merck KGaA Names Hong Chow as Head of China International for Healthcare
CI
07/26MARKETMIND : A China crackdown
RE
07/23MERCK KOMMANDITGESELLSCHAFT AUF AKTI : KGaA Appoints China, International Market..
MT
07/23MERCK KGAA : JP Morgan reiterates its Buy rating
MD
07/23MARKETMIND : Lower forever for 'Generation T'?
RE
07/22MERCK : Launches Green Solvents Line for Semiconductor Manufacturers
MT
More news
News in other languages on MERCK KGAA
07/27MÄRKTE EUROPA/Etwas leichter - Vorlagen aus China belasten
07/19DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 19.07.2021 - 15.15 Uhr
07/19Merck investiert 270 Millionen in Forschungs- und Ausbildungszentrum
07/19Merck investiert 270 Mio EUR in Forschungs- und Weiterbildungszentrum
07/15Merck erhält in Großbritannien positive Beurteilung für Tepotinib
More news
Analyst Recommendations on MERCK KGAA
More recommendations
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | MarketScreener
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 173,30 €
Average target price 155,43 €
Spread / Average Target -10,3%
EPS Revisions
Managers and Directors
BelÚn Garijo Lˇpez Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz BŘchele Chairman-Supervisory Board
Maria Rivas Chief Medical Officer & Senior Vice President
Laura Matz Chief Science & Technology Officer
Sector and Competitors